Likely due to a low CD8+ T cell number in the TGF-β-TRAP–treated tumor, no significantly DEGs were identified between the TGF-β-TRAP–treated tumor and control-treated tumor in CD8+ T cells (Supplemental Figure 13G). This evidence concerns the gene CD8A and neoplasm.